Qura Raises €1.5 Million in Pre-Seed Funding
Milan-based Qura, a health-tech startup offering comprehensive medical analysis, personalized consultation, and tailored health plans through a single subscription, has successfully raised €1.5 million in a pre-seed funding round. The round was led by United Ventures, with additional participation from Vento and Italian Angels for Growth (IAG).
Founders and Leadership
Qura was co-founded by Virginia Gambardella, who also serves as the CEO, and Gio Grand, the Chief Technology Officer. The company aims to fill a significant gap in the healthcare market by addressing ongoing subclinical symptoms that many traditional healthcare systems find challenging to manage effectively.
The Need for Integrated Health Solutions
Healthcare systems often focus primarily on acute treatment, leaving many non-emergency and chronic conditions inadequately addressed. Qura aims to tackle this issue by offering an integrated care pathway. Their approach includes comprehensive blood testing through partner laboratories, followed by personalized health plans and consultations.
Use of Funds
While the company has not disclosed detailed plans for the newly raised funds, the investment is expected to enhance Qura's AI-powered platform and expand its service offerings. With the healthcare check-up market projected to grow significantly, this funding round positions Qura to better meet the rising demand for preventive care solutions.
Investors
Led by United Ventures, the funding round also saw participation from Vento and Italian Angels for Growth (IAG). These investors are betting on Qura's potential to innovate within the healthcare sector and address the unmet needs of individuals experiencing non-acute health issues.
Conclusion
Qura's successful funding round highlights the growing interest in health-tech solutions that offer more personalized and comprehensive care. As the company advances its platform, it aims to make significant strides in improving the quality of life for individuals dealing with chronic health concerns that are often overlooked by conventional healthcare systems.